首页 > 产品展示 > 单克隆抗体
rHep B vaccine (BTG)
Hepatitis B is one of a few known non-retroviralviruses which employ reverse transcriptionas a part of its replication process. (HIV, a completely unrelated virus, also uses reverse transcription, but it is a retrovirus.) HBV invades the cell by binding to surface receptor and become internalized. The viral core particles then migrate to the hepatocyte nucleus and the partially double-stranded, relaxed circular genomes (RC-DNA) are repaired to form a covalently closed circular DNA (cccDNA), which is the template for viral genomic and sub-genomic RNAs by cellular RNA polymerase II. Of these, the pregenomic RNA (pgRNA is selectively packaged into progeny capsids and is then reverse-transcribed into new RC-DNA. The core can either bud into the endoplasmic reticulum to be enveloped or exported from the cell or recycled back into the genome for conversion to cccDNA.
  • Name: rHep B vaccine (BTG)
  • Synonyms:
  • Catalogue Number:PTAB1430016
  • Application:Direct ELISA, Western Blot, Immuneprecipitation, immunohistochemistry.
  • Price: 100ug ¥3200.00
  • Number:
  • Concentration:1mg/ml in PBS with 50% Glycerol.
  • Store:-20oC
Cat No.: PTAB1430016
Product Name: rHep B vaccine (BTG)
Type: Protein
Property:
Origin:
Source: mouse
Application: Direct ELISA, Western Blot, Immuneprecipitation, immunohistochemistry.
Formulation:
Purity: >95% by SDS-PAGE gel
Storage: Avoid repeated freeze-thaw cycles. 12 months at -20 C to -80 C. 1 month at 2 C to 8 C.
Limitation:
Note: